Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in New Facility
April 04 2014 - 8:30AM
Marketwired
Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in
New Facility
NEW YORK, NY--(Marketwired - Apr 4, 2014) - Plandaí
Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with
a brand new state of the art production facility that is due to be
fully operational sometime this month. Plandaí recently finished
the all-important Stage 2 on the Senteeko Tea Estate in South
Africa. It's this section of the factory that CEO Roger Duffield
says "the magic of Phytofare" takes place. Plandaí will make its
money and its mark in the biotechnology sector here as it's where
the proprietary hydrodynamic sheering process will takes place.
Plandaí and its subsidiaries develop highly bioavailable,
phytonutrient rich extracts which are being utilized to deliver a
new family of drugs to safely and affordably treat a multitude of
diseases and conditions. In order to develop these highly
bioavailable extracts, it requires Plandaí's unique extraction
process that uses live plant material grown on the tea estate and a
combination of temperature and a unique wave of acoustic energy to
release the living phytonutrients, rearranging the polyenes into a
bio-compatible form.
Plandaí's CEO said of this process, "The magic of Phytofare
involves unzipping the molecule to release the valuable
phytonutrients, which we have now done for the first time on an
industrial scale."
So, with stage 1 and 2 done, the company has turned to
completing stage 3, the only section remaining between Plandaí and
the introduction of its Phytofare™ extracts to the public. The
third stage of Plandaí's process separates out the solids and any
unnecessary elements, rendering pharmaceutical-grade, purified
catechins in mainly nano-particle form.
As Plandaí reaches the finish line on the production facility,
Duffield said, "It is exciting to see the culmination of over ten
years of research and effort on the part of countless
supporters."
About Stock Market Media Group SMMG is a full service IR firm
specializing in Research and Content Development. It offers a
platform for corporate stories to unfold through the media with
Reports, Interviews and Articles. SMMG is compensated for Plandaí
articles, reports and interviews by a third party who reserves the
right to buy, sell or remain neutral on securities at any time
before, during, or after the publication of this article. To date,
SMMG has received total compensation of $39,190, for content
related to Plandaí. For more information:
www.stockmarketmediagroup.com/disclaimer.
Contact: Stock Market Media Group Email Contact
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Sep 2023 to Sep 2024